메뉴 건너뛰기




Volumn 57, Issue 10, 2013, Pages 4760-4781

Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; BREFELDIN A; ERGOSTEROL; FLUCONAZOLE; PYRROLE; STEROL 14ALPHA DEMETHYLASE; VORICONAZOLE; FUNGAL PROTEIN; PYRROLE DERIVATIVE;

EID: 84884217484     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00477-13     Document Type: Article
Times cited : (25)

References (73)
  • 1
    • 77950471425 scopus 로고    scopus 로고
    • Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: A 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion
    • Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, Rodloff A, Fu W, Ling TA. 2010. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J. Clin. Microbiol. 48: 1366-1377.
    • (2010) J. Clin. Microbiol. , vol.48 , pp. 1366-1377
    • Pfaller, M.A.1    Diekema, D.J.2    Gibbs, D.L.3    Newell, V.A.4    Ellis, D.5    Tullio, V.6    Rodloff, A.7    Fu, W.8    Ling, T.A.9
  • 3
    • 79958066469 scopus 로고    scopus 로고
    • Candida bloodstream infections: Comparison of species distribution and resistance to echinocandin and azole antifungal agents in intensive care unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009)
    • Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M. 2011. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in intensive care unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). Int. J. Antimicrob. Agents 38:65-69.
    • (2011) Int. J. Antimicrob. Agents , vol.38 , pp. 65-69
    • Pfaller, M.A.1    Messer, S.A.2    Moet, G.J.3    Jones, R.N.4    Castanheira, M.5
  • 6
    • 80052619814 scopus 로고    scopus 로고
    • Species distribution and anti-fungal susceptibility of candidaemia at a multi super-speciality center in Southern India
    • Adhikary R, Joshi S. 2011. Species distribution and anti-fungal susceptibility of candidaemia at a multi super-speciality center in Southern India. Indian J. Med. Microbiol. 29:309-311.
    • (2011) Indian J. Med. Microbiol. , vol.29 , pp. 309-311
    • Adhikary, R.1    Joshi, S.2
  • 7
    • 77955295116 scopus 로고    scopus 로고
    • Candida tropicalis: Its prevalence, pathogenicity and increasing resistance to fluconazole
    • Kothavade RJ, Kura MM, Valand AG, Panthaki MH. 2010. Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole. J. Med. Microbiol. 59:873-880.
    • (2010) J. Med. Microbiol. , vol.59 , pp. 873-880
    • Kothavade, R.J.1    Kura, M.M.2    Valand, A.G.3    Panthaki, M.H.4
  • 13
    • 2942718513 scopus 로고    scopus 로고
    • Clinical significance of breakthrough fungemia caused by azole-resistant Candida tropicalis in patients with hematologic malignancies
    • Myoken Y, Kyo T, Fujihara M, Sugata T, Mikami Y. 2004. Clinical significance of breakthrough fungemia caused by azole-resistant Candida tropicalis in patients with hematologic malignancies. Haematologica 89: 378-380.
    • (2004) Haematologica , vol.89 , pp. 378-380
    • Myoken, Y.1    Kyo, T.2    Fujihara, M.3    Sugata, T.4    Mikami, Y.5
  • 15
    • 43749123271 scopus 로고    scopus 로고
    • Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006
    • Yang YL, Wang AH, Wang CW, Cheng WT, Li SY, Lo HJ; TSARY Hospitals. 2008. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006. Diagn. Microbiol. Infect. Dis. 61:175-180.
    • (2008) Diagn. Microbiol. Infect. Dis. , vol.61 , pp. 175-180
    • Yang, Y.L.1    Wang, A.H.2    Wang, C.W.3    Cheng, W.T.4    Li, S.Y.5    Lo, H.J.6    Hospitals, T.7
  • 19
    • 0036488166 scopus 로고    scopus 로고
    • Resistance of Candida species to antifungal agents: Molecular mechanisms and clinical consequences
    • Sanglard D, Odds FC. 2002. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2:73-85.
    • (2002) Lancet Infect. Dis. , vol.2 , pp. 73-85
    • Sanglard, D.1    Odds, F.C.2
  • 20
    • 84055199809 scopus 로고    scopus 로고
    • Antifungal drug resistance: Mechanisms, epidemiology, and consequences for treatment
    • Pfaller MA. 2012. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am. J. Med. 125:S3-S13.
    • (2012) Am. J. Med. , vol.125
    • Pfaller, M.A.1
  • 21
    • 0034812585 scopus 로고    scopus 로고
    • Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients
    • Perea S, López-Ribot JL, Kirkpatrick WR, McAtee RK, Santillán RA, Martínez M, Calabrese D, Sanglard D, Patterson TF. 2001. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 45:2676-2684.
    • (2001) Antimicrob. Agents Chemother. , vol.45 , pp. 2676-2684
    • Perea, S.1    López-Ribot, J.L.2    Kirkpatrick, W.R.3    McAtee, R.K.4    Santillán, R.A.5    Martínez, M.6    Calabrese, D.7    Sanglard, D.8    Patterson, T.F.9
  • 22
    • 77749291956 scopus 로고    scopus 로고
    • Screening for amino acid substitutions in the Candida albicans Erg11 protein of azolesusceptible and azole-resistant clinical isolates: New substitutions and a review of the literature
    • Morio F, Loge C, Besse B, Hennequin C, Le Pape P. 2010. Screening for amino acid substitutions in the Candida albicans Erg11 protein of azolesusceptible and azole-resistant clinical isolates: new substitutions and a review of the literature. Diagn. Microbiol. Infect. Dis. 66:373-384.
    • (2010) Diagn. Microbiol. Infect. Dis. , vol.66 , pp. 373-384
    • Morio, F.1    Loge, C.2    Besse, B.3    Hennequin, C.4    Le Pape, P.5
  • 23
    • 0032733078 scopus 로고    scopus 로고
    • Y132H substitution in Candida albicans sterol 14-demethylase confers fluconazole resistance by preventing binding to haem
    • Kelly SL, Lamb DC, Kelly DE. 1999. Y132H substitution in Candida albicans sterol 14-demethylase confers fluconazole resistance by preventing binding to haem. FEMS Microbiol. Lett. 180:171-175.
    • (1999) FEMS Microbiol. Lett. , vol.180 , pp. 171-175
    • Kelly, S.L.1    Lamb, D.C.2    Kelly, D.E.3
  • 24
    • 0031938057 scopus 로고    scopus 로고
    • Amino acid substitutions in the cytochrome P-450 lanosterol 14-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents
    • Sanglard D, Ischer F, Koymans L, Bille J. 1998. Amino acid substitutions in the cytochrome P-450 lanosterol 14-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob. Agents Chemother. 42:241-253.
    • (1998) Antimicrob. Agents Chemother. , vol.42 , pp. 241-253
    • Sanglard, D.1    Ischer, F.2    Koymans, L.3    Bille, J.4
  • 25
    • 84864577072 scopus 로고    scopus 로고
    • Fungal cytochrome P450 sterol 14-demethylase (CYP51) and azole resistance in plant and human pathogens
    • Becher R, Wirsel SG. 2012. Fungal cytochrome P450 sterol 14-demethylase (CYP51) and azole resistance in plant and human pathogens. Appl. Microbiol. Biotechnol. 95:825-840.
    • (2012) Appl. Microbiol. Biotechnol. , vol.95 , pp. 825-840
    • Becher, R.1    Wirsel, S.G.2
  • 26
    • 0346784897 scopus 로고    scopus 로고
    • Three-dimensional models of wild-type and mutated forms of cytochrome P450 14-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding
    • Xiao L, Madison V, Chau AS, Loebenberg D, Palermo RE, McNicholas PM. 2004. Three-dimensional models of wild-type and mutated forms of cytochrome P450 14-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding. Antimicrob. Agents Chemother. 48:568-574.
    • (2004) Antimicrob. Agents Chemother. , vol.48 , pp. 568-574
    • Xiao, L.1    Madison, V.2    Chau, A.S.3    Loebenberg, D.4    Palermo, R.E.5    McNicholas, P.M.6
  • 27
    • 84875276783 scopus 로고    scopus 로고
    • Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China
    • Jiang C, Dong D, Yu B, Cai G, Wang X, Ji Y, Peng Y. 2013. Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China. J. Antimicrob. Chemother. 68:778-785.
    • (2013) J. Antimicrob. Chemother. , vol.68 , pp. 778-785
    • Jiang, C.1    Dong, D.2    Yu, B.3    Cai, G.4    Wang, X.5    Ji, Y.6    Peng, Y.7
  • 29
    • 77950180902 scopus 로고    scopus 로고
    • Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection
    • MacCallum DM, Coste A, Ischer F, Jacobsen MD, Odds FC, Sanglard D. 2010. Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection. Antimicrob. Agents Chemother. 54:1476-1483.
    • (2010) Antimicrob. Agents Chemother. , vol.54 , pp. 1476-1483
    • Maccallum, D.M.1    Coste, A.2    Ischer, F.3    Jacobsen, M.D.4    Odds, F.C.5    Sanglard, D.6
  • 31
    • 84860906111 scopus 로고    scopus 로고
    • Selecting an invertebrate model host for the study of fungal pathogenesis
    • doi:10.1371/journal.ppat.1002451
    • Desalermos A, Fuchs BB, Mylonakis E. 2012. Selecting an invertebrate model host for the study of fungal pathogenesis. PLoS Pathog. 8:e1002451. doi:10.1371/journal.ppat.1002451.
    • (2012) PLoS Pathog. , vol.8
    • Desalermos, A.1    Fuchs, B.B.2    Mylonakis, E.3
  • 32
    • 79960442678 scopus 로고    scopus 로고
    • Wax moth larva (Galleria mellonella): An in vivo model for assessing the efficacy of antistaphylococcal agents
    • Desbois AP, Coote PJ. 2011. Wax moth larva (Galleria mellonella): an in vivo model for assessing the efficacy of antistaphylococcal agents. J. Antimicrob. Chemother. 66:1785-1790.
    • (2011) J. Antimicrob. Chemother. , vol.66 , pp. 1785-1790
    • Desbois, A.P.1    Coote, P.J.2
  • 35
    • 81955164780 scopus 로고    scopus 로고
    • Fusarium pathogenesis investigated using Galleria mellonella as a heterologous host
    • Coleman JJ, Muhammed M, Kasperkovitz PV, Vyas JM, Mylonakis E. 2011. Fusarium pathogenesis investigated using Galleria mellonella as a heterologous host. Fungal Biol. 115:1279-1289.
    • (2011) Fungal Biol. , vol.115 , pp. 1279-1289
    • Coleman, J.J.1    Muhammed, M.2    Kasperkovitz, P.V.3    Vyas, J.M.4    Mylonakis, E.5
  • 36
    • 79951500577 scopus 로고    scopus 로고
    • Pathogenicity of Aspergillus fumigatus mutants assessed in Galleria mellonella matches that in mice
    • Slater JL, Gregson L, Denning DW, Warn PA. 2011. Pathogenicity of Aspergillus fumigatus mutants assessed in Galleria mellonella matches that in mice. Med. Mycol. 49:S107-S113.
    • (2011) Med. Mycol. , vol.49
    • Slater, J.L.1    Gregson, L.2    Denning, D.W.3    Warn, P.A.4
  • 37
    • 84879926068 scopus 로고    scopus 로고
    • The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast
    • Mesa-Arango AC, Forastiero A, Bernal-Martínez L, Cuenca-Estrella M, Mellado E, Zaragoza O. 2013. The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast. Med. Mycol. 51:461-472.
    • (2013) Med. Mycol. , vol.51 , pp. 461-472
    • Mesa-Arango, A.C.1    Forastiero, A.2    Bernal-Martínez, L.3    Cuenca-Estrella, M.4    Mellado, E.5    Zaragoza, O.6
  • 39
    • 84862606187 scopus 로고    scopus 로고
    • EUCAST technical note on the EUCAST definitive document EDef 7.2: Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)
    • Arendrup MC, Cuenca-Estrella M, Lass-Flörl C, Hope W. EUCASTAFST. 2012. EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST). Clin. Microbiol. Infect. 18:E246-E247.
    • (2012) Clin. Microbiol. Infect. , vol.18
    • Arendrup, M.C.1    Cuenca-Estrella, M.2    Lass-Flörl, C.3    Eucastafst, H.W.4
  • 40
    • 81255127375 scopus 로고    scopus 로고
    • EUCAST technical note on amphotericin B
    • European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing
    • Lass-Flörl C, Arendrup MC, Rodriguez-Tudela JL, Cuenca-Estrella M, Donnelly P, Hope W; European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing. 2011. EUCAST technical note on amphotericin B. Clin. Microbiol. Infect. 17:E27-E29.
    • (2011) Clin. Microbiol. Infect. , vol.17
    • Lass-Flörl, C.1    Arendrup, M.C.2    Rodriguez-Tudela, J.L.3    Cuenca-Estrella, M.4    Donnelly, P.5    Hope, W.6
  • 42
    • 0043270593 scopus 로고    scopus 로고
    • Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents
    • Sanglard D, Ischer F, Parkinson T, Falconer D, Bille J. 2003. Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob. Agents Chemother. 47:2404-2412.
    • (2003) Antimicrob. Agents Chemother. , vol.47 , pp. 2404-2412
    • Sanglard, D.1    Ischer, F.2    Parkinson, T.3    Falconer, D.4    Bille, J.5
  • 44
    • 0035991849 scopus 로고    scopus 로고
    • Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates
    • for the Candidemia Active Surveillance Group
    • Arthington-Skaggs BA, Lee-Yang W, Ciblak MA, Frade JP, Brandt ME, Hajjeh RA, Harrison LH, Sofair AN, Warnock DW, for the Candidemia Active Surveillance Group. 2002. Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates. Antimicrob. Agents Chemother. 46:2477-2481.
    • (2002) Antimicrob. Agents Chemother. , vol.46 , pp. 2477-2481
    • Arthington-Skaggs, B.A.1    Lee-Yang, W.2    Ciblak, M.A.3    Frade, J.P.4    Brandt, M.E.5    Hajjeh, R.A.6    Harrison, L.H.7    Sofair, A.N.8    Warnock, D.W.9
  • 46
    • 0035057290 scopus 로고    scopus 로고
    • Ergosterol biosynthesis in novel melanized fungi from hypersaline environments
    • Méjanelle L, Lòpez JF, Gunde-Cimerman N, Grimalt JO. 2001. Ergosterol biosynthesis in novel melanized fungi from hypersaline environments. J. Lipid Res. 42:352-358.
    • (2001) J. Lipid Res. , vol.42 , pp. 352-358
    • Méjanelle, L.1    Lòpez, J.F.2    Gunde-Cimerman, N.3    Grimalt, J.O.4
  • 48
    • 32144432437 scopus 로고    scopus 로고
    • The SWISS-MODEL workspace: A web-based environment for protein structure homology modelling
    • Arnold K, Bordoli L, Kopp J, Schwede T. 2006. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22:195-201.
    • (2006) Bioinformatics , vol.22 , pp. 195-201
    • Arnold, K.1    Bordoli, L.2    Kopp, J.3    Schwede, T.4
  • 50
    • 0029004590 scopus 로고
    • Protein modeling by E-mail
    • Peitsch MC. 1995. Protein modeling by E-mail. Bio/Technology 13:658-660.
    • (1995) Bio/Technology , vol.13 , pp. 658-660
    • Peitsch, M.C.1
  • 51
    • 77950023120 scopus 로고    scopus 로고
    • Structural basis of human CYP51 inhibition by antifungal azoles
    • Strushkevich N, Usanov SA, Park HW. 2010. Structural basis of human CYP51 inhibition by antifungal azoles. J. Mol. Biol. 397:1067-1078.
    • (2010) J. Mol. Biol. , vol.397 , pp. 1067-1078
    • Strushkevich, N.1    Usanov, S.A.2    Park, H.W.3
  • 52
    • 0032865613 scopus 로고    scopus 로고
    • Rhodamine 6G efflux for the detection of CDR1 overexpressing azoleresistant Candida albicans strains
    • Maesaki S, Marichal P, Vanden Bossche H, Sanglard D, Kohno S. 1999. Rhodamine 6G efflux for the detection of CDR1 overexpressing azoleresistant Candida albicans strains. J. Antimicrob. Chemother. 44:27-31.
    • (1999) J. Antimicrob. Chemother. , vol.44 , pp. 27-31
    • Maesaki, S.1    Marichal, P.2    Vanden Bossche, H.3    Sanglard, D.4    Kohno, S.5
  • 53
    • 0032540222 scopus 로고    scopus 로고
    • Assessing protein structures with a non-local atomic interaction energy
    • Melo F, Feytmans E. 1998. Assessing protein structures with a non-local atomic interaction energy. J. Mol. Biol. 277:1141-1152.
    • (1998) J. Mol. Biol. , vol.277 , pp. 1141-1152
    • Melo, F.1    Feytmans, E.2
  • 56
    • 84864389183 scopus 로고    scopus 로고
    • Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B
    • Hull CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG, Kelly DE, Kelly SL. 2012. Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B. Antimicrob. Agents Chemother. 56:4223-4232.
    • (2012) Antimicrob. Agents Chemother. , vol.56 , pp. 4223-4232
    • Hull, C.M.1    Parker, J.E.2    Bader, O.3    Weig, M.4    Gross, U.5    Warrilow, A.G.6    Kelly, D.E.7    Kelly, S.L.8
  • 57
    • 0035853108 scopus 로고    scopus 로고
    • Crystal structure of cytochrome P450 14-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors
    • Podust LM, Poulos TL, Waterman MR. 2001. Crystal structure of cytochrome P450 14-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc. Natl. Acad. Sci. U. S. A. 98:3068-3073.
    • (2001) Proc. Natl. Acad. Sci. U. S. A. , vol.98 , pp. 3068-3073
    • Podust, L.M.1    Poulos, T.L.2    Waterman, M.R.3
  • 59
    • 2542494102 scopus 로고    scopus 로고
    • Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles
    • Chau AS, Mendrick CA, Sabatelli FJ, Loebenberg D, McNicholas PM. 2004. Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles. Antimicrob. Agents Chemother. 48:2124-2131.
    • (2004) Antimicrob. Agents Chemother. , vol.48 , pp. 2124-2131
    • Chau, A.S.1    Mendrick, C.A.2    Sabatelli, F.J.3    Loebenberg, D.4    McNicholas, P.M.5
  • 60
    • 84863164890 scopus 로고    scopus 로고
    • Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/ posaconazole
    • Sionov E, Chang YC, Garraffo HM, Dolan MA, Ghannoum MA, Kwon-Chung KJ. 2012. Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/ posaconazole. Antimicrob. Agents Chemother. 56:1162-1169.
    • (2012) Antimicrob. Agents Chemother. , vol.56 , pp. 1162-1169
    • Sionov, E.1    Chang, Y.C.2    Garraffo, H.M.3    Dolan, M.A.4    Ghannoum, M.A.5    Kwon-Chung, K.J.6
  • 63
    • 0033584392 scopus 로고    scopus 로고
    • The G464S amino acid substitution in Candida albicans sterol 14α-demethylase causes fluconazole resistance in the clinic through reduced affinity
    • Kelly SL, Lamb DC, Loeffler J, Einsele H, Kelly DE. 1999. The G464S amino acid substitution in Candida albicans sterol 14α-demethylase causes fluconazole resistance in the clinic through reduced affinity. Biochem. Biophys. Res. Commun. 262:174-179.
    • (1999) Biochem. Biophys. Res. Commun. , vol.262 , pp. 174-179
    • Kelly, S.L.1    Lamb, D.C.2    Loeffler, J.3    Einsele, H.4    Kelly, D.E.5
  • 65
    • 79959615872 scopus 로고    scopus 로고
    • Molecular modelling of the emergence of azole resistance in Mycosphaerella graminicola
    • doi:10.1371 /journal.pone.0020973
    • Mullins JGL, Parker JE, Cools HJ, Togawa RC, Lucas JA, Fraaije BA, Kelly DE, Kelly S. 2011. Molecular modelling of the emergence of azole resistance in Mycosphaerella graminicola. PLoS One 6:e20973. doi:10.1371 /journal.pone. 0020973.
    • (2011) PLoS One , vol.6
    • Jgl, M.1    Parker, J.E.2    Cools, H.J.3    Togawa, R.C.4    Lucas, J.A.5    Fraaije, B.A.6    Kelly, D.E.7    Kelly, S.8
  • 66
    • 0042544006 scopus 로고    scopus 로고
    • A mutation in the 14-demethylase gene of Uncinula necator that correlates with resistance to a sterol biosynthesis inhibitor
    • Délye C, Laigret F, Corio-Costet MF. 1997. A mutation in the 14-demethylase gene of Uncinula necator that correlates with resistance to a sterol biosynthesis inhibitor. Appl. Environ. Microbiol. 63:2966-2970.
    • (1997) Appl. Environ. Microbiol. , vol.63 , pp. 2966-2970
    • Délye, C.1    Laigret, F.2    Corio-Costet, M.F.3
  • 68
    • 0032428659 scopus 로고    scopus 로고
    • PCR cloning and detection of point mutations in the eburicol 14-demethylase (CYP51) gene from Erysiphe graminis F. Sp. Hordei, a "recalcitrant" fungus
    • Délye C, Bousset L, Corio-Costet MF. 1998. PCR cloning and detection of point mutations in the eburicol 14-demethylase (CYP51) gene from Erysiphe graminis f. sp. hordei, a "recalcitrant" fungus. Curr. Genet. 34:399-403.
    • (1998) Curr. Genet. , vol.34 , pp. 399-403
    • Délye, C.1    Bousset, L.2    Corio-Costet, M.F.3
  • 69
    • 0028942449 scopus 로고
    • Mode of action and resistance to azole antifungals associated with the formation of 14-methylergosta-8,24(28)-dien-3,6-diol
    • Kelly SL, Lamb DC, Corran AJ, Baldwin BC, Kelly DE. 1995. Mode of action and resistance to azole antifungals associated with the formation of 14-methylergosta-8,24(28)-dien-3,6-diol. Biochem. Biophys. Res. Commun. 207:910-915.
    • (1995) Biochem. Biophys. Res. Commun. , vol.207 , pp. 910-915
    • Kelly, S.L.1    Lamb, D.C.2    Corran, A.J.3    Baldwin, B.C.4    Kelly, D.E.5
  • 71
    • 84865368550 scopus 로고    scopus 로고
    • Amino acid substitutions in the Candida albicans sterol δ5,6-desaturase (Erg3p) confer azole resistance: Characterization of two novel mutants with impaired virulence
    • Morio F, Pagniez F, Lacroix C, Miegeville M, Le Pape P. 2012. Amino acid substitutions in the Candida albicans sterol δ5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence. J. Antimicrob. Chemother. 67:2131-2138.
    • (2012) J. Antimicrob. Chemother. , vol.67 , pp. 2131-2138
    • Morio, F.1    Pagniez, F.2    Lacroix, C.3    Miegeville, M.4    Le Pape, P.5
  • 73
    • 1242351240 scopus 로고    scopus 로고
    • Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens
    • Kavanagh K, Reeves EP. 2004. Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens. FEMS Microbiol. Rev. 28:101-112.
    • (2004) FEMS Microbiol. Rev. , vol.28 , pp. 101-112
    • Kavanagh, K.1    Reeves, E.P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.